Skip to main content
. 2016 Apr 7;7(4):e2183. doi: 10.1038/cddis.2016.89

Figure 7.

Figure 7

β-Arrestin-1 and β-arrestin-2 negatively regulated ATG12–ATG5 conjugation system in podocytes with HG treatment. (a) Representative western blotting gel documents and summarized data showing the effect of Arrb1 knockdown on the levels of ATG12–ATG5 and LC3-II/LC3-I. (b) Representative western blotting gel documents and summarized data showing the effect of Arrb2 knockdown on the levels of ATG12–ATG5 and LC3-II/LC3-I. (c) Immunoprecipitation assay showing that β-arrestin-1/2 interacted with ATG7 and the interactions between ATG7 and β-arrestin-1/2 were significantly enhanced in podocytes with HG treatment. (means±S.E.M.; n=6; *P<0.05 versus control, †P<0.05 versus scramble of HG treatment). (d) Representative western blotting gel documents and summarized data showing the levels of ATG12–ATG5 and LC3-II/LC3-I in the kidney from Arrb1−/− diabetic mice. (e) Representative western blotting gel documents and summarized data showing the levels of ATG12–ATG5 and LC3-II/LC3-I in the kidney from Arrb2−/− diabetic mice. Values are means±S.E.M.; *P<0.05 versus control, †P<0.05 versus WT STZ mice (n=8)